|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Mediomics, LLC Receives Phase II SBIR Contract: Awarded $997,251 to Develop New In-Process Analyzer for Biologics
10/24/2012 9:28:37 AM
ST. LOUIS--(BUSINESS WIRE)--Mediomics, LLC has been awarded a $997,251 Phase II SBIR contract (HHSN261201200081C) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. This project builds on successful Phase I research, and aims to develop a fully automated in-process analyzer to monitor the titer and quality of recombinant biologics. Using Mediomics’ innovative molecular PINCER® platform, Phase II work will include development of more quantitative antigen-specific assays for antibody titer, affinity, glycosylation and aggregation. This project will culminate with beta-testing by Gallus Biopharmaceuticals, a leading cGMP biologics contract manufacturing organization.
|
|
|
|
|
|
|
|
|
|
|